December 3, 2020

The Niche

Knoepfler lab stem cell blog

CEO John Scarlett

3 min read

When you want to both know the real history of the pluripotent stem cell-based biotech industry and perspectives on its future, there are only a handful of people to turn to and one of them is definitely Dr. Michael West, CEO of BioTime. I’m doing a several part series of blog posts on a lengthy phone interview and conversation that I had with West. Today in Part 2 we are focused on clinical development of human ES cells and what happened with Geron. You …Read More